Review



nonparametric spearman correlation statistic test mystat 12.0  (SYSTAT)


Bioz Verified Symbol SYSTAT is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    SYSTAT nonparametric spearman correlation statistic test mystat 12.0
    Nonparametric Spearman Correlation Statistic Test Mystat 12.0, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/mystat+12/pm35014479-117-9-16
    Average 90 stars, based on 1 article reviews
    nonparametric spearman correlation statistic test mystat 12.0 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
    Article Snippet: GNAO1 variants were recently discovered as causes of epileptic encephalopathies and heterogeneous syndromes presenting with movement disorders (MDs), whose phenomenology and clinical course are yet undefined.. We herein focused on GNAO1-related MD, providing an analytical review of existing data to outline the main MD phenomenology and management, clinical evolution and genotypephenotype correlations.. Reviewing 41 previously published patients and assessing 5 novel cases, a comprehensive cohort of 46 patients was analyzed, reassuming knowledge about genotypes, phenotypes, disease course and treatment of this condition.

    Article Title: Ibuprofen loaded PVA/chitosan membranes: A highly efficient strategy towards an improved skin wound healing.
    Article Snippet: During wound healing, an early inflammation can cause an increase of the wound size and the healing process can be considerably belated if a disproportionate inflammatory response occurs. (S)-ibuprofen (IBP), a non-steroidal anti-inflammatory agent, has been used for muscle healing and to treat venous leg ulcers, but its effect in skin wound healing has not been thoroughly studied thus far.. Herein, IBPβ-cyclodextrins carriers were designed to customise the release profile of IBP from poly(vinyl alcohol)/chitosan (PVA/CS) dressings in order to promote a faster skin regeneration.. The dressings were produced using supercritical carbon dioxide (scCO2)-assisted technique.

    Article Title: Does Bypass of the Proximal Small Intestine Impact Food Intake, Preference, and Taste Function in Humans? An Experimental Medicine Study Using the Duodenal-Jejunal Bypass Liner
    Article Snippet: C-values were calculated using Mystat ® (Systat ® 12) software (Cranes Software International Ltd., Palo Alto, CA, USA).

    Article Title: Detection of Reproducible Major Effect QTL for Petal Traits in Garden Roses
    Article Snippet: The statistical calculations were performed in Excel 2016, MYSTAT 12 (Systat Software, Inc., San Jose, CA, USA), Past 4.02 [ ] and QtiPlot 1.0.0.

    Article Title: Responders to intradiscal glucocorticoid among patients with chronic low back pain and active discopathy.
    Article Snippet: SIR, Active discopathy is a plausible nociceptive cause of non-specific chronic low back pain (cLBP) in patients with inflammatory-like cLBP and Modic 1 changes on MRI [1].. Clinical trials have suggested that intradiscal therapies could reduce LBP in the short term [2, 3].. However, baseline characteristics associated with response to intradiscal therapies among patients with cLBP and active discopathy are unknown.

    Article Title: Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial
    Article Snippet: Statistical analysis including t-test, Mann-Whitney-U-test, Wilcoxon-test, Pearson-correlation and Spearman-rang-correlation were performed with SigmaStat 3.1 (Systat Software Inc., USA, 2004), Mystat 12.02.00 (student version, Systat) and OriginPro 8 SR0.

    Article Title: Amphiphilic Graft Copolymers Capable of Mixed-Mode Interaction as Alternative Nonviral Transfection Agents.
    Article Snippet: Nonviral gene delivery vectors are attractive candidates compared to viral ones due to their lower cytotoxicity and immunogenicity.. However, their efficacy still requires improvement.. Major challenges are the effective complexation and protection of the DNA cargo and the intracellular dissociation of the polyplexes at the site of action.



    Similar Products

    90
    GraphPad Software Inc two-tailed, nonparametric spearman correlation test
    Two Tailed, Nonparametric Spearman Correlation Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+statistics+graphpad+prism/pm40399675-700-15-20
    Average 90 stars, based on 1 article reviews
    two-tailed, nonparametric spearman correlation test - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman correlation tests
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman Correlation Tests, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+spearman+correlation/pmc11633857-104-10-16
    Average 90 stars, based on 1 article reviews
    nonparametric spearman correlation tests - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman's rank correlation tests graphpad prism version 10.0.0
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman's Rank Correlation Tests Graphpad Prism Version 10.0.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+spearman+s+rank+correlation+tests+graphpad+prism+version+10+0+0/pm38603619-92-6-12
    Average 90 stars, based on 1 article reviews
    nonparametric spearman's rank correlation tests graphpad prism version 10.0.0 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric statistical spearman correlation test using graphpad prism® 9.1.2
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Statistical Spearman Correlation Test Using Graphpad Prism® 9.1.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+statistical+spearman+correlation+test+using+graphpad+prism++9+1+2/pmc10823629-100-28-30
    Average 90 stars, based on 1 article reviews
    nonparametric statistical spearman correlation test using graphpad prism® 9.1.2 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    SAS institute spearman nonparametric rank correlation test
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Spearman Nonparametric Rank Correlation Test, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+wilcoxon+test/pm36451287-45-31-36
    Average 90 stars, based on 1 article reviews
    spearman nonparametric rank correlation test - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman’s rank correlation test on graphpad prism
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman’s Rank Correlation Test On Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+spearman%E2%80%99s+rank+correlation+test+on+graphpad+prism/pm37238718-64-13-13
    Average 90 stars, based on 1 article reviews
    nonparametric spearman’s rank correlation test on graphpad prism - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    SYSTAT nonparametric spearman correlation statistic test mystat 12.0
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman Correlation Statistic Test Mystat 12.0, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/mystat+12/pm35014479-117-9-16
    Average 90 stars, based on 1 article reviews
    nonparametric spearman correlation statistic test mystat 12.0 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman’s correlation test
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman’s Correlation Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/spearman+nonparametric+correlation+analysis/10__1172_slash_jci154422-342-5-9
    Average 90 stars, based on 1 article reviews
    nonparametric spearman’s correlation test - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric correlation spearman test by graphpad 8
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Correlation Spearman Test By Graphpad 8, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+correlation+spearman+test/nonparametric+friedman+test+graphpad+8/pm32885549-201-17-23
    Average 90 stars, based on 1 article reviews
    nonparametric correlation spearman test by graphpad 8 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the nonparametric Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.

    Journal: Biomaterials Research

    Article Title: Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo

    doi: 10.34133/bmr.0112

    Figure Lengend Snippet: Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the nonparametric Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.

    Article Snippet: Correlation analysis in Fig. A to C were performed using nonparametric Spearman correlation tests, also using GraphPad Prism 8.0.

    Techniques: Injection, Concentration Assay, Clinical Proteomics, Comparison, Derivative Assay